Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Exploratory Study of Pre-Operative Treatment With Erlotinib (Tarceva) in Muscle Invasive or Recurrent Transitional Cell Carcinoma Requiring Cystectomy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00749892
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:02.143775+00:00
Published At
2020-09-10T00:00:00+00:00
Record Updated At
2020-09-10
Results Posted At
2020-09-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Bladder Urothelial Carcinoma", "Recurrent Renal Pelvis Urothelial Carcinoma", "Recurrent Ureter Urothelial Carcinoma", "Recurrent Urethral Urothelial Carcinoma", "Stage 0a Bladder Cancer AJCC v8", "Stage 0a Renal Pelvis Cancer AJCC v8", "Stage 0a Ureter Cancer AJCC v8", "Stage 0a Urethral Cancer AJCC v8", "Stage 0is Bladder Cancer AJCC v8", "Stage 0is Renal Pelvis Cancer AJCC v8", "Stage 0is Ureter Cancer AJCC v8", "Stage 0is Urethral Cancer AJCC v8", "Stage II Bladder Cancer AJCC v8", "Stage II Renal Pelvis Cancer AJCC v8", "Stage II Ureter Cancer AJCC v8", "Stage II Urethral Cancer AJCC v8", "Stage III Renal Pelvis Cancer AJCC v8", "Stage III Ureter Cancer AJCC v8", "Stage III Urethral Cancer AJCC v8", "Stage IIIA Bladder Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-09-10"
protocolSection.identificationModule.nctId
"NCT00749892"
protocolSection.identificationModule.officialTitle
"A Phase II Exploratory Study of Pre-Operative Treatment With Erlotinib (Tarceva) in Muscle Invasive or Recurrent Transitional Cell Carcinoma Requiring Cystectomy"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-09-10"

Study condition terms

  • Recurrent Bladder Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Renal Pelvis Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ureter Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Urethral Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage 0a Bladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage 0a Renal Pelvis Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage 0a Ureter Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage 0a Urethral Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage 0is Bladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage 0is Renal Pelvis Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage 0is Ureter Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage 0is Urethral Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage II Bladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage II Renal Pelvis Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage II Ureter Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage II Urethral Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Renal Pelvis Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Ureter Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Urethral Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Bladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.